Drug Targets – Products
Product News
NanoTemper Technologies Launches Spectral Shift
NanoTemper Technologies has announced the launch of Spectral Shift technology within their Dianthus instrument, built to handle the most challenging affinity-based screenings in drug discovery.
Product News
Agilent Announces the Innovative Seahorse XF Pro Analyzer
Agilent Technologies Inc. has announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools.
Whitepaper
Research Tools for Anti-Cancer Drug Targets
Currently, various treatments are available to cancer patients, such as chemotherapy, targeted therapy and immunotherapy. Targeted therapy is a type of precision medicine that targets the proteins that control the growth, division and spread of cancer cells.
Product
Advertisement
SomaScan Assay: The World's Largest Proteomic Platform
Discover more with the first and only technology that can measure 7,000 proteins over a broad range of concentrations. Built on 20 years of pioneering proteomics technology, The SomaScan Assay enables unprecedented biomarker and drug discovery and now, you can seamlessly transition from discovery to validation with new SomaScan panels and SomaSignal TM Tests bolstering the entire drug discovery and development pipeline, all via a straightforward fee-for-service model.
Product
Advertisement
Synthetic Immune Recruitment – A New Way To Fight Tumors
The utility and efficiency of the Octet® platform at characterizing covalent immune recruiter molecule function and their efficacy as modulators of protein proximity was demonstrated. Efficient in vitro validation further enables the potential acceleration of CIR translation to in vivo model validation and the clinic as a new class of synthetic tumor immunotherapeutic.
Product News
Applications of Bioluminescent Research Tools Showcased at Global Seminar Series
Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of luciferase technologies during the upcoming Discover Glo 2021 virtual seminar series.
Product
Advertisement
SomaScan Assay: The World's Largest Proteomic Platform
The SomaScan® Assay is the first and only technology that can measure 7,000 proteins over a wide range of concentrations, enabling unprecedented discovery for a variety of disease applications. The SomaScan proteomics platform supports the entire drug discovery and development pipeline from biomarker exploration to clinical trial monitoring. You can get started using the SomaScan Assay today with no set-up fees, and you maintain full ownership of your data.
Product News
Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics
Thermo Fisher Scientific and the University of California, Davis West Coast Metabolomics Center have announced The Center of Excellence in Clinical Metabolomics, a research collaboration to provide the metabolomics community with innovations, best practices and standard operating procedures to support the rapid scale-up of large cohort studies and clinical research.
App Note / Case Study
Greater Precision for Transformative Drug Discovery
Target identification and characterization are key challenges in drug discovery and begin with identifying the function of a possible therapeutic target and its role in the disease.
App Note / Case Study
Automated Immunoprecipitation With Seamless Integration to Protein Analysis
Download this app note to discover an automated immunoprecipitation method that offers seamless integration to protein analysis, ensures high yield and reproducibility as well as delivers low nonspecific binding with significant reductions in total and hands-on time.
Advertisement